Long-Term Study Suggests Extended Relief from Atopic Dermatitis After Topical Treatment
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
The regenerative biostimulator is now certified for use in four new body areas.